ロード中...
Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean
BACKGROUND: RotaTeq™ (RV5; Merck & Co. Inc., USA) and Rotarix™ (RV1, GlaxoSmithKline, Belgium) vaccines, developed to prevent rotavirus diarrhea in children under five years old, were both introduced into national immunization programs in 2006. As many countries in Latin America and the Caribbea...
保存先:
| 出版年: | BMC Pediatr |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237165/ https://ncbi.nlm.nih.gov/pubmed/28086819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-016-0771-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|